Magstim’s Horizon Performance Platform Approved in Europe

Magstim received a CE Mark for its Horizon Performance platform, which is used to treat depression in patients by applying magnetic pulse therapy.

The treatment uses transcranial magnetic stimulation, avoiding drug side effects and invasive treatments.

It has been used in situations where antidepressant treatments are ineffective and before invasive therapies — such as electroconvulsive therapy — are considered.